Market Cap 12.77B
Revenue (ttm) 13.64B
Net Income (ttm) 746.80M
EPS (ttm) N/A
PE Ratio 16.94
Forward PE 13.18
Profit Margin 5.47%
Debt to Equity Ratio -22.49
Volume 586,295
Avg Vol 879,160
Day's Range N/A - N/A
Shares Out 64.20M
Stochastic %K 96%
Beta 0.84
Analysts Sell
Price Target $190.50

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administ...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 720 631 2100
Address:
2000 16th Street, Denver, United States
Noname2022
Noname2022 May. 13 at 11:25 AM
$CRMD $AKBA $FMS $DVA https://www.govtrack.us/congress/bills/119/hr6214/cosponsors
0 · Reply
Noname2022
Noname2022 May. 13 at 8:09 AM
$DVA $AKBA https://bofa.veracast.com/webcasts/bofa/healthcare2026/xS0mL9.cfm Davita talked about generic auryxia specifically * minimal impaxt on ASP due to small supply :( Mentioned DVA gets $50M / year binder benefit still Opportunity to discuss specifics on TDAPA drugs was asked but again declined
0 · Reply
OpenOutcrier
OpenOutcrier May. 12 at 8:05 PM
RECAP 5/12 -Neg Comments: $RZLV - FACT Capital $OSIS - Blue Orca $DVA - Third North $SNAP - Freedom Broker $RY - Ray Jay Live Breaking trading news www.openoutcrier.com
0 · Reply
Noname2022
Noname2022 May. 12 at 7:44 PM
0 · Reply
CapitalMonk
CapitalMonk May. 12 at 4:18 PM
$DVA Price: $199.79 (+0.43%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.57% RSI: 86.8 | Momentum: Strong Momentum Volume: -65.6% vs avg Volatility: 5.38% Support: $143.07 | Resistance: $202.13 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Noname2022
Noname2022 May. 12 at 2:38 AM
0 · Reply
MorganHoratio
MorganHoratio May. 11 at 9:25 PM
Today, all of these stocks hit all-time highs at some point. United Microelectronics $UMC Teck Resources $TECK Davita Healthcare $DVA Camtek $CAMT F5 Inc $FFIV Today’s All-Time High (ATH) list showcases a powerful rally spreading across "Foundries, Healthcare, and Cloud Security"! 🚀 The standout is $CAMT, hitting a historic $215.99. As a leader in advanced packaging inspection, it is riding the massive HBM expansion wave. Meanwhile, $UMC reaching $15.9 proves the robust recovery of mature nodes driven by edge AI. Additionally, record highs for $DVA and $FFIV highlight that high-cash-flow giants remain a preferred haven for institutional capital in 2026. This confirms that the 2026 bull run has evolved beyond GPUs into a collective re-rating of industry leaders. Which of these ATH stocks do you think has the strongest fundamental support for another 2X run? Let’s talk strategy in the comments!
0 · Reply
Noname2022
Noname2022 May. 10 at 3:23 PM
$DVA $FMS $CRMD https://www.investing.com/news/transcripts/earnings-call-transcript-fresenius-medical-care-q1-2026-beats-eps-expectations-93CH-4659185
2 · Reply
OptionRunners
OptionRunners May. 8 at 7:01 PM
$DVA big roll in these calls after a big earnings move. They're adding $562K to the position, betting on further upside.
0 · Reply
Noname2022
Noname2022 May. 8 at 2:21 AM
0 · Reply
Latest News on DVA
DaVita price target raised to $201 from $144 at TD Cowen

2026-05-11T14:28:21.000Z - 2 days ago

DaVita price target raised to $201 from $144 at TD Cowen


DaVita price target raised to $205 from $158 at Truist

2026-05-08T11:57:34.000Z - 5 days ago

DaVita price target raised to $205 from $158 at Truist


DaVita price target raised to $235 from $190 at UBS

2026-05-07T13:29:05.000Z - 6 days ago

DaVita price target raised to $235 from $190 at UBS


DaVita price target raised to $194 from $158 at Barclays

2026-05-07T11:44:30.000Z - 6 days ago

DaVita price target raised to $194 from $158 at Barclays


DaVita upgraded to Buy from Hold at Deutsche Bank

2026-05-07T10:41:29.000Z - 6 days ago

DaVita upgraded to Buy from Hold at Deutsche Bank


DaVita rises 19.6%

2026-05-07T03:38:03.000Z - 6 days ago

DaVita rises 19.6%


DaVita Earnings Call Transcript: Q1 2026

May 5, 2026, 5:00 PM EDT - 8 days ago

DaVita Earnings Call Transcript: Q1 2026


DaVita reports Q1 EPS $2.87, consensus $2.33

2026-05-05T20:28:38.000Z - 8 days ago

DaVita reports Q1 EPS $2.87, consensus $2.33


DaVita Inc. 1st Quarter 2026 Results

May 5, 2026, 4:05 PM EDT - 8 days ago

DaVita Inc. 1st Quarter 2026 Results


DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call

Apr 20, 2026, 2:06 PM EDT - 23 days ago

DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call


DaVita Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 11:50 AM EST - 2 months ago

DaVita Transcript: TD Cowen 46th Annual Health Care Conference


DaVita price target raised to $158 from $128 at Truist

2026-02-05T15:05:21.000Z - 3 months ago

DaVita price target raised to $158 from $128 at Truist


DaVita price target raised to $144 from $133 at TD Cowen

2026-02-04T13:50:41.000Z - 3 months ago

DaVita price target raised to $144 from $133 at TD Cowen


DaVita price target raised to $190 from $186 at UBS

2026-02-04T11:36:08.000Z - 3 months ago

DaVita price target raised to $190 from $186 at UBS


DaVita rises 21.7%

2026-02-03T17:05:35.000Z - 3 months ago

DaVita rises 21.7%


TER Quarterly Sales Top $1B, DVA & PEP Beat Earnings

Feb 3, 2026, 11:00 AM EST - 3 months ago

TER Quarterly Sales Top $1B, DVA & PEP Beat Earnings

PEP TER


DaVita Earnings Call Transcript: Q4 2025

Feb 2, 2026, 5:00 PM EST - 3 months ago

DaVita Earnings Call Transcript: Q4 2025


DaVita Inc. 4th Quarter 2025 Results

Feb 2, 2026, 4:05 PM EST - 3 months ago

DaVita Inc. 4th Quarter 2025 Results


DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call

Jan 21, 2026, 10:00 AM EST - 4 months ago

DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call


DaVita Names New Leaders to Accelerate Care Transformation

Dec 11, 2025, 8:00 AM EST - 5 months ago

DaVita Names New Leaders to Accelerate Care Transformation


DaVita Transcript: Wolfe Research Healthcare Conference 2025

Nov 17, 2025, 11:20 AM EST - 6 months ago

DaVita Transcript: Wolfe Research Healthcare Conference 2025


DaVita Inc. to Participate in Fireside Chat with Wolfe Research

Nov 14, 2025, 4:16 PM EST - 6 months ago

DaVita Inc. to Participate in Fireside Chat with Wolfe Research


DaVita Earnings Call Transcript: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 7 months ago

DaVita Earnings Call Transcript: Q3 2025


DaVita Inc. 3rd Quarter 2025 Results

Oct 29, 2025, 4:05 PM EDT - 7 months ago

DaVita Inc. 3rd Quarter 2025 Results


DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call

Oct 13, 2025, 2:00 PM EDT - 7 months ago

DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call


DaVita Earnings Call Transcript: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 10 months ago

DaVita Earnings Call Transcript: Q2 2025


DaVita Inc. 2nd Quarter 2025 Results

Aug 5, 2025, 4:05 PM EDT - 10 months ago

DaVita Inc. 2nd Quarter 2025 Results


DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

Jul 17, 2025, 5:37 PM EDT - 10 months ago

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call


DaVita Inc. Announces Offering of $750 Million Senior Notes

May 20, 2025, 8:51 AM EDT - 1 year ago

DaVita Inc. Announces Offering of $750 Million Senior Notes


DaVita Earnings Call Transcript: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings Call Transcript: Q1 2025


DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:51 PM EDT - 1 year ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers


DaVita Inc. 1st Quarter 2025 Results

May 12, 2025, 4:05 PM EDT - 1 year ago

DaVita Inc. 1st Quarter 2025 Results


DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 30, 2025, 11:00 AM EDT - 1 year ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call


DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:35 AM EDT - 1 year ago

DaVita Says Ransomware Attack Affecting Some Operations


Dialysis firm DaVita hit by ransomware attack

Apr 14, 2025, 7:33 AM EDT - 1 year ago

Dialysis firm DaVita hit by ransomware attack


Berkshire Hathaway sells another 750,000 DaVita shares

Feb 19, 2025, 8:05 PM EST - 1 year ago

Berkshire Hathaway sells another 750,000 DaVita shares


Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 8:13 PM EST - 1 year ago

Berkshire sells some DaVita shares, cuts stake to 45%


DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 6:07 PM EST - 1 year ago

DaVita forecasts 2025 profit below estimates, shares plummet


DaVita Earnings Call Transcript: Q4 2024

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Earnings Call Transcript: Q4 2024


DaVita Inc. 4th Quarter 2024 Results

Feb 13, 2025, 4:05 PM EST - 1 year ago

DaVita Inc. 4th Quarter 2024 Results


DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Jan 30, 2025, 11:55 AM EST - 1 year ago

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call


DaVita Transcript: UBS Global Healthcare Conference 2024

Nov 12, 2024, 3:30 PM EST - 1 year ago

DaVita Transcript: UBS Global Healthcare Conference 2024


Noname2022
Noname2022 May. 13 at 11:25 AM
$CRMD $AKBA $FMS $DVA https://www.govtrack.us/congress/bills/119/hr6214/cosponsors
0 · Reply
Noname2022
Noname2022 May. 13 at 8:09 AM
$DVA $AKBA https://bofa.veracast.com/webcasts/bofa/healthcare2026/xS0mL9.cfm Davita talked about generic auryxia specifically * minimal impaxt on ASP due to small supply :( Mentioned DVA gets $50M / year binder benefit still Opportunity to discuss specifics on TDAPA drugs was asked but again declined
0 · Reply
OpenOutcrier
OpenOutcrier May. 12 at 8:05 PM
RECAP 5/12 -Neg Comments: $RZLV - FACT Capital $OSIS - Blue Orca $DVA - Third North $SNAP - Freedom Broker $RY - Ray Jay Live Breaking trading news www.openoutcrier.com
0 · Reply
Noname2022
Noname2022 May. 12 at 7:44 PM
0 · Reply
CapitalMonk
CapitalMonk May. 12 at 4:18 PM
$DVA Price: $199.79 (+0.43%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.57% RSI: 86.8 | Momentum: Strong Momentum Volume: -65.6% vs avg Volatility: 5.38% Support: $143.07 | Resistance: $202.13 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Noname2022
Noname2022 May. 12 at 2:38 AM
0 · Reply
MorganHoratio
MorganHoratio May. 11 at 9:25 PM
Today, all of these stocks hit all-time highs at some point. United Microelectronics $UMC Teck Resources $TECK Davita Healthcare $DVA Camtek $CAMT F5 Inc $FFIV Today’s All-Time High (ATH) list showcases a powerful rally spreading across "Foundries, Healthcare, and Cloud Security"! 🚀 The standout is $CAMT, hitting a historic $215.99. As a leader in advanced packaging inspection, it is riding the massive HBM expansion wave. Meanwhile, $UMC reaching $15.9 proves the robust recovery of mature nodes driven by edge AI. Additionally, record highs for $DVA and $FFIV highlight that high-cash-flow giants remain a preferred haven for institutional capital in 2026. This confirms that the 2026 bull run has evolved beyond GPUs into a collective re-rating of industry leaders. Which of these ATH stocks do you think has the strongest fundamental support for another 2X run? Let’s talk strategy in the comments!
0 · Reply
Noname2022
Noname2022 May. 10 at 3:23 PM
$DVA $FMS $CRMD https://www.investing.com/news/transcripts/earnings-call-transcript-fresenius-medical-care-q1-2026-beats-eps-expectations-93CH-4659185
2 · Reply
OptionRunners
OptionRunners May. 8 at 7:01 PM
$DVA big roll in these calls after a big earnings move. They're adding $562K to the position, betting on further upside.
0 · Reply
Noname2022
Noname2022 May. 8 at 2:21 AM
0 · Reply
Noname2022
Noname2022 May. 8 at 1:00 AM
$AKBA $DVA https://www.vafseohcp.com/pdf/prescribing-information.pdf https://www.investing.com/news/transcripts/earnings-call-transcript-akebias-q1-2026-results-miss-forecasts-stock-drops-93CH-4667831
0 · Reply
Noname2022
Noname2022 May. 7 at 10:12 PM
1 · Reply
Noname2022
Noname2022 May. 7 at 5:56 PM
$AKBA $CRMD $DVA $FMS K-CAPA lobbying…
1 · Reply
SweStonk
SweStonk May. 7 at 8:18 AM
$CRMD Defencath save lives and money. We just need to give it enough time and everything will play out just as we want and that is to bring in alot of dollars. When whoever that sit and make the true decision for defencath and see that it save them both LIVES and MONEY they will be on it faster than a heartbeat. I have no doubt in that. We just need to have patience and give it time and we will be paid for it 🫡 During the meantime enjoy the ride while it lasts 😉 $XBI $DVA
0 · Reply
topstockalerts
topstockalerts May. 7 at 12:28 AM
$DVA this could easily turn into one of those annoying runners you miss 😅
0 · Reply
LewisDaKat
LewisDaKat May. 6 at 10:00 PM
$DVA DaVita (DVA) Q1 2026 Earnings Transcript https://marketwirenews.com/stock/dva/news/davita-dva-q1-2026-earnings-transcript-6269314034852873.html?utm_source=stocktwits
0 · Reply
MaverikIT
MaverikIT May. 6 at 9:48 PM
$DVA - Nice day
0 · Reply
LewisDaKat
LewisDaKat May. 6 at 9:30 PM
$DVA DVA Price Target Alert: $220.00. Issued by Deutsche Bank https://marketwirenews.com/stock/dva/news/dva-price-target-alert-220-00-issued-by-deutsche-ban-5135348066397365.html?utm_source=stocktwits
0 · Reply
LewisDaKat
LewisDaKat May. 6 at 9:00 PM
$DVA Buy Recommendation Issued On DVA By Deutsche Bank https://marketwirenews.com/stock/dva/news/buy-recommendation-issued-on-dva-by-deutsche-bank-6907466396577077.html?utm_source=stocktwits
0 · Reply
QuantInsider
QuantInsider May. 6 at 8:30 PM
$DVA just went wild with a 23.5% pop in one day No news driving it but options flow tells the story At 9:37am, about 3,300 July and October calls traded at the ask with $7.6M in premium Notably, the Oct $190S with 1,500 contracts versus 8 OI showed up as a top position on InsiderFinance Looks like institutions are loading up for a bullish ride over the next few months With this kind of volatility, risk management is key Given the stock's insane +25% five-day run, it's in a high-volatility zone Better to keep positions tight with spreads or defined-risk setups rather than going all in
0 · Reply
Noname2022
Noname2022 May. 6 at 8:06 PM
1 · Reply
Chingying
Chingying May. 6 at 5:23 PM
$DVA PT$ 220 Deutsche
0 · Reply